Rockefeller Capital Management L.P. Invests $2.49 Million in Grail, Inc. (NASDAQ:GRAL)

Rockefeller Capital Management L.P. purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL) during the 4th quarter, Holdings Channel reports. The fund purchased 139,489 shares of the company’s stock, valued at approximately $2,490,000.

Other institutional investors also recently bought and sold shares of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Grail in the fourth quarter valued at $244,000. Moloney Securities Asset Management LLC bought a new position in Grail during the 4th quarter valued at about $559,000. Rhumbline Advisers purchased a new stake in Grail in the 4th quarter worth about $456,000. Wesbanco Bank Inc. bought a new stake in Grail in the fourth quarter worth about $523,000. Finally, Slow Capital Inc. purchased a new position in shares of Grail during the fourth quarter valued at approximately $2,379,000.

Grail Stock Performance

NASDAQ GRAL opened at $27.00 on Friday. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The company’s 50-day moving average price is $32.83 and its 200-day moving average price is $23.64.

Grail (NASDAQ:GRAL) last issued its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. As a group, equities research analysts expect that Grail, Inc. will post -15.15 earnings per share for the current year.

Insiders Place Their Bets

In other news, President Joshua J. Ofman sold 2,109 shares of the firm’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $65,800.80. Following the transaction, the president now owns 559,673 shares in the company, valued at approximately $17,461,797.60. This trade represents a 0.38 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $56,659.20. Following the completion of the sale, the chief financial officer now owns 335,170 shares of the company’s stock, valued at $10,457,304. The trade was a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,550 shares of company stock worth $360,436 in the last ninety days.

Wall Street Analyst Weigh In

Separately, Morgan Stanley increased their price target on Grail from $16.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.